Well Lead Medical Co., Ltd. (SHA:603309)

Market Cap	3.53B
Revenue (ttm)	1.55B
Net Income (ttm)	228.06M
Shares Out	292.87M
EPS (ttm)	0.78
PE Ratio	15.47
Forward PE	12.19
Dividend	0.50 (4.14%)
Ex-Dividend Date	May 29, 2025

Volume	3,392,915
Average Volume	3,166,630
Open	12.02
Previous Close	12.00
Day's Range	12.00 - 12.19
52-Week Range	9.45 - 14.67
Beta	-0.09
RSI	52.63
Earnings Date	Jul 25, 2025

About Well Lead Medical

Well Lead Medical Co., Ltd. engages in the development, production, and sale of medical devices in anaesthesia, urology, endourology, respiratory, pain management, and hemodialysis areas worldwide. It manufactures and sells urology products, including Foley catheter, Nelaton catheters, urine collection products, and accessories; endourology products, such as the ClearPetra family system, ureterorenoscope, guide wires, ureteral stent, and stone retrieval basket; anesthesia products, comprising endotracheal tubes, intubation accessories, laryngea...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1998
• Employees: 2,622
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603309

Financial Performance

In 2024, Well Lead Medical's revenue was 1.51 billion, an increase of 8.76% compared to the previous year's 1.39 billion. Earnings were 219.39 million, an increase of 13.98%.